SRXH

SEC Filing Summary: SRx Health Solutions, Inc. (SRXH)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2025. SRx Health Solutions, Inc. (formerly Better Choice Company, Inc.) operates as a vertically integrated healthcare organization and branded pet wellness company. The reporting reflects the results of a reverse merger completed on April 24, 2025, between SRx Canada (Accounting Acquirer) and Better Choice (Legal Acquirer). The Company operates two segments: Health Solutions (Canadian pharmacy and clinical services) and Consumer Products (Halo pet food business).

Material Subsequent Event: On August 12, 2025, the Company's Canadian subsidiary, SRx Canada, filed for protection under the Companies' Creditors Arrangement Act (CCAA) in Canada due to liquidity constraints and covenant violations.

Key Financial Metrics (Nine Months Ended June 30, 2025)

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 65% to $41.1 million, primarily due to liquidity constraints limiting the purchase and dispensing of high-cost specialty medications in the Health Solutions segment.
• Increased Expenses: SG&A expenses rose 26% to $39.8 million, driven by transaction costs related to the reverse merger and share-based compensation ($4.5 million vs. $2.6 million).
• Impairment Charges: The Company recorded a $2.7 million impairment expense related to customer list intangible assets in the Health Solutions segment.
• Asset Disposals: The Company recognized a net gain of $4.3 million from the sale of various pharmacy assets and a warehouse building to improve liquidity.
• Merger Impact: The reverse merger resulted in a bargain purchase gain of $1.7 million. The Consumer Products segment (Halo) contributed $2.7 million in revenue post-merger.

Outlook, Risks, and Contingencies

• Going Concern: The filing explicitly states substantial doubt about the Company's ability to continue as a going concern due to recurring losses, negative operating cash flows, and working capital deficiencies.
• Debt Covenants: As of June 30, 2025, the Company was not in compliance with financial covenants under its senior secured term facilities with Canadian Western Bank (CWB). Consequently, the debt has been classified as current and is callable.
• Restructuring: The August 2025 CCAA filing aims to facilitate a court-supervised restructuring, including potential divestitures and workforce reductions. The outcome remains uncertain.
• Internal Controls: The Company identified material weaknesses in internal controls over financial reporting, including issues with revenue documentation, fair value determinations, and management override of controls.
• Share Cancellation: Subsequent to the period end, approximately 18.8 million shares (46% of fully diluted capital) were cancelled following a settlement with former founders.

Investor Verification Checklist

• CCAA Status: Verify the current status of the CCAA proceedings and the likelihood of a successful restructuring plan or asset sale.
• Liquidity Runway: Assess the sufficiency of the $0.9 million cash balance against immediate debt obligations and operating burn rates.
• Debt Restructuring: Confirm if the CWB debt covenant violations have been resolved or if the debt has been accelerated.
• Capital Structure: Review the impact of the 18.8 million share cancellation and recent convertible note issuances on shareholder dilution.
• Internal Controls: Evaluate the remediation plan for the identified material weaknesses in financial reporting.